Using the Laser in Correcting Anemia in Hemodialysis Patients
Identifieur interne : 005617 ( Main/Exploration ); précédent : 005616; suivant : 005618Using the Laser in Correcting Anemia in Hemodialysis Patients
Auteurs : R. Z. Ismagilov [Kazakhstan] ; V. U. Dreizin [Kazakhstan] ; A. S. Azhitaeva [Kazakhstan]Source :
- Hemodialysis International [ 1492-7535 ] ; 2004-01.
Abstract
One of the main symptoms of terminal‐stage chronic renal insufficiency is anemia. One of the best applicable methods correcting anemia is using recombinant human erythropoietin preparation. Using recombinant human erythropoietin in patients with terminal‐stage chronic renal insufficiency in 90–95% of events had a positive effect, but 5–10% of patient had refraction to erythropoietin, which has spurred the search for new efficient methods correcting anemia. The purpose of the study was to determine the influence of the laser on erythropoiesis and blood acid–alkaline condition (pH) in patients with terminal‐stage chronic renal insufficiency. In the course of the study, erythrocytes, hemoglobin, reticulocytes in blood, and blood acid–alkaline condition (pH) were determined. At the beginning of the treatment, all hematological parameters 5 and 15 days after marrow stimulation were defined. 15 days after marrow stimulation with laser, increasing amounts of erythrocytes, hemoglobin, and hematocrit were observed. The initial erythrocyte count was 2.22 ± 0.1 × 1012/L, hemoglobin 67.7 ± 3.2 g/L and hematocrit 18.2 ± 1.2%. During the laser treatment, erythrocyte count increased up to 2.9 ± 0.8 × 1012/L, hemoglobin up to 89.6 ± 2.9 g/L and hematocrit up to 28.2 ± 1.3% (p < 0005).
Url:
DOI: 10.1111/j.1492-7535.2004.0085aw.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001473
- to stream Istex, to step Curation: 001473
- to stream Istex, to step Checkpoint: 001C95
- to stream Main, to step Merge: 005A63
- to stream Main, to step Curation: 005617
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Using the Laser in Correcting Anemia in Hemodialysis Patients</title><author><name sortKey="Ismagilov, R Z" sort="Ismagilov, R Z" uniqKey="Ismagilov R" first="R. Z." last="Ismagilov">R. Z. Ismagilov</name></author><author><name sortKey="Dreizin, V U" sort="Dreizin, V U" uniqKey="Dreizin V" first="V. U." last="Dreizin">V. U. Dreizin</name></author><author><name sortKey="Azhitaeva, A S" sort="Azhitaeva, A S" uniqKey="Azhitaeva A" first="A. S." last="Azhitaeva">A. S. Azhitaeva</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E763DDC0F56B1B080EA944085D9D02DA506944C0</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1111/j.1492-7535.2004.0085aw.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-RMTBLMLZ-2/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001473</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001473</idno><idno type="wicri:Area/Istex/Curation">001473</idno><idno type="wicri:Area/Istex/Checkpoint">001C95</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001C95</idno><idno type="wicri:doubleKey">1492-7535:2004:Ismagilov R:using:the:laser</idno><idno type="wicri:Area/Main/Merge">005A63</idno><idno type="wicri:Area/Main/Curation">005617</idno><idno type="wicri:Area/Main/Exploration">005617</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Using the Laser in Correcting Anemia in Hemodialysis Patients</title><author><name sortKey="Ismagilov, R Z" sort="Ismagilov, R Z" uniqKey="Ismagilov R" first="R. Z." last="Ismagilov">R. Z. Ismagilov</name><affiliation wicri:level="3"><country xml:lang="fr">Kazakhstan</country><wicri:regionArea>Syzganov Scientific Center of Surgery, Almaty</wicri:regionArea><placeName><settlement type="city">Almaty</settlement><region nuts="2">Oblys d'Almaty</region></placeName></affiliation></author><author><name sortKey="Dreizin, V U" sort="Dreizin, V U" uniqKey="Dreizin V" first="V. U." last="Dreizin">V. U. Dreizin</name><affiliation wicri:level="3"><country xml:lang="fr">Kazakhstan</country><wicri:regionArea>Syzganov Scientific Center of Surgery, Almaty</wicri:regionArea><placeName><settlement type="city">Almaty</settlement><region nuts="2">Oblys d'Almaty</region></placeName></affiliation></author><author><name sortKey="Azhitaeva, A S" sort="Azhitaeva, A S" uniqKey="Azhitaeva A" first="A. S." last="Azhitaeva">A. S. Azhitaeva</name><affiliation wicri:level="3"><country xml:lang="fr">Kazakhstan</country><wicri:regionArea>Syzganov Scientific Center of Surgery, Almaty</wicri:regionArea><placeName><settlement type="city">Almaty</settlement><region nuts="2">Oblys d'Almaty</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Hemodialysis International</title><title level="j" type="alt">HEMODIALYSIS INTERNATIONAL</title><idno type="ISSN">1492-7535</idno><idno type="eISSN">1542-4758</idno><imprint><biblScope unit="vol">8</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="97">97</biblScope><biblScope unit="page" to="97">97</biblScope><biblScope unit="page-count">100</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK; Malden, USA</pubPlace><date type="published" when="2004-01">2004-01</date></imprint><idno type="ISSN">1492-7535</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1492-7535</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">One of the main symptoms of terminal‐stage chronic renal insufficiency is anemia. One of the best applicable methods correcting anemia is using recombinant human erythropoietin preparation. Using recombinant human erythropoietin in patients with terminal‐stage chronic renal insufficiency in 90–95% of events had a positive effect, but 5–10% of patient had refraction to erythropoietin, which has spurred the search for new efficient methods correcting anemia. The purpose of the study was to determine the influence of the laser on erythropoiesis and blood acid–alkaline condition (pH) in patients with terminal‐stage chronic renal insufficiency. In the course of the study, erythrocytes, hemoglobin, reticulocytes in blood, and blood acid–alkaline condition (pH) were determined. At the beginning of the treatment, all hematological parameters 5 and 15 days after marrow stimulation were defined. 15 days after marrow stimulation with laser, increasing amounts of erythrocytes, hemoglobin, and hematocrit were observed. The initial erythrocyte count was 2.22 ± 0.1 × 1012/L, hemoglobin 67.7 ± 3.2 g/L and hematocrit 18.2 ± 1.2%. During the laser treatment, erythrocyte count increased up to 2.9 ± 0.8 × 1012/L, hemoglobin up to 89.6 ± 2.9 g/L and hematocrit up to 28.2 ± 1.3% (p < 0005).</div></front></TEI><affiliations><list><country><li>Kazakhstan</li></country><region><li>Oblys d'Almaty</li></region><settlement><li>Almaty</li></settlement></list><tree><country name="Kazakhstan"><region name="Oblys d'Almaty"><name sortKey="Ismagilov, R Z" sort="Ismagilov, R Z" uniqKey="Ismagilov R" first="R. Z." last="Ismagilov">R. Z. Ismagilov</name></region><name sortKey="Azhitaeva, A S" sort="Azhitaeva, A S" uniqKey="Azhitaeva A" first="A. S." last="Azhitaeva">A. S. Azhitaeva</name><name sortKey="Dreizin, V U" sort="Dreizin, V U" uniqKey="Dreizin V" first="V. U." last="Dreizin">V. U. Dreizin</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005617 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005617 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:E763DDC0F56B1B080EA944085D9D02DA506944C0
|texte= Using the Laser in Correcting Anemia in Hemodialysis Patients
}}
| This area was generated with Dilib version V0.6.33. |  |